Daily Dose of Bifemelane: 150mg
Bifemelane is a nootropic, meaning a smart drug or food for the brain. For many in the modern age, to be successful in a career and academics depends on how sharp your mind is at all times. The sharp witted tend to triumph over those who have not cultivated their bodies’ most important organ, and thus they are left behind. To stay ahead of the competition, it is a good idea to boost brain function and nootropics can do just that. One of the main functions of nootropics is to enhance the learning ability, concentration, attention, and memory of the person experimenting. Another function of a nootropic is to protect the brain from physical or chemical injury. With these positive effects of enhancing cognitive ability and memory, it may also improve overall intelligence and keep motivation levels high. Bifemelane is used for the treatment of senile dementia. Besides its nootropic effects, it is also has neuroprotective and antidepressant effects. Bifemelane is also useful in treating Glaucoma.
Nootrpoics like Bifemelane work by increasing neurotransmitter activity, improving blood flow to the brain, and stimulating nerve growth. Boosting blood flow to the brain is an important role in nootropics because the brain gets a better supply of oxygen, glucose, and other nutrients needed for effective brain function. Unfortunately, the only downside to nootropics is that many only have temporary effects. In order to keep seeing positive benefits of the nootropic, it must be taken on a regular basis. When someone stops taking nootropics, their brain function and intelligence will eventually revert back to normal. The recommended dosage of Bifemalane to treat Cerebrovascular disorders in adults is 150mg a day taken in divided doses. Some of its common side effects include headaches, drowsiness, nausea, vomiting, anxiety, and insomnia.
- Yoshida Y, Kumagai H, Ohkubo Y, Tsuchiya R, Morita M, Miyakawa H, Kudo Y. Effects of bifemelane on the calcium level and ATP release of the human origin astrocyte clonal cell. J Pharmacol Sci. 2006 Sep;102(1):121-8. PMID: 16974067.
- Yoshida Y, Nakane A, Morita M, Kudo Y. A novel effect of bifemelane, a nootropic drug, on intracellular Ca2+ levels in rat cerebral astrocytes. J Pharmacol Sci. 2006 Feb;100(2):126-32. PMID: 16474207.
- Shigemitsu T, Majima Y. Use of bifemelane hydrochloride in improving and maintaining the visual field of patients with glaucoma. Clin Ther. 1996 Jan-Feb;18(1):106-13. PMID: 8851457.